Charlemagne Capital
Latest statistics and disclosures from Charlemagne Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ITUB, BABA, BBD, Petrobras Energia Participaciones SA, BIDU, and represent 43.92% of Charlemagne Capital's stock portfolio.
- Added to shares of these 10 stocks: BRFS (+$10M), YPF (+$9.3M), Petrobras Energia Participaciones SA (+$7.8M), PAM, BABA, BMA, EPAM, SUPV, VIPS, TEO.
- Started 2 new stock positions in YPF, Synergy Pharmaceuticals.
- Reduced shares in these 10 stocks: , ABEV, ITUB, MELI, TAL, Luxoft Holding Inc cmn, GGAL, Nord Anglia Education, TGS, BIDU.
- Sold out of its positions in GGAL, Vimpel, Nord Anglia Education.
- Charlemagne Capital was a net buyer of stock by $7.9M.
- Charlemagne Capital has $213M in assets under management (AUM), dropping by 23.29%.
- Central Index Key (CIK): 0001351841
Tip: Access up to 7 years of quarterly data
Positions held by Charlemagne Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Charlemagne Capital
Charlemagne Capital holds 39 positions in its portfolio as reported in the March 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Banco Itau Holding Financeira (ITUB) | 14.5 | $31M | -6% | 2.6M | 12.08 |
|
Alibaba Group Holding (BABA) | 10.1 | $21M | +11% | 198k | 108.09 |
|
Banco Bradesco SA (BBD) | 7.6 | $16M | 1.6M | 10.30 |
|
|
Petrobras Energia Participaciones SA | 6.0 | $13M | +156% | 1.2M | 11.06 |
|
Baidu (BIDU) | 5.8 | $12M | -4% | 71k | 173.01 |
|
Edenor (EDN) | 5.1 | $11M | +11% | 312k | 34.65 |
|
BRF Brasil Foods SA (BRFS) | 4.8 | $10M | +6901% | 829k | 12.27 |
|
Pampa Energia (PAM) | 4.4 | $9.3M | +49% | 171k | 54.42 |
|
Ypf Sa (YPF) | 4.4 | $9.3M | NEW | 383k | 24.21 |
|
Depository Vipshop Holdings Ltd - Ads receipt (VIPS) | 4.0 | $8.4M | +18% | 631k | 13.34 |
|
Transportadora de Gas del Sur SA (TGS) | 3.7 | $7.9M | -7% | 555k | 14.24 |
|
Luxoft Holding Inc cmn | 3.6 | $7.7M | -11% | 122k | 62.60 |
|
Fomento Economico Mexicano SAB (FMX) | 3.5 | $7.5M | -5% | 85k | 88.62 |
|
Credicorp (BAP) | 3.4 | $7.1M | -6% | 44k | 163.55 |
|
Ambev Sa- (ABEV) | 3.2 | $6.8M | -31% | 1.2M | 5.77 |
|
Banco Macro SA (BMA) | 2.8 | $5.9M | +52% | 68k | 86.55 |
|
Petroleo Brasileiro SA (PBR.A) | 2.5 | $5.3M | -8% | 571k | 9.25 |
|
Telecom Argentina (TEO) | 2.2 | $4.8M | +33% | 215k | 22.11 |
|
TAL Education (TAL) | 2.2 | $4.7M | -24% | 44k | 106.48 |
|
Grupo Supervielle S A (SUPV) | 2.0 | $4.2M | +49% | 246k | 16.98 |
|
Epam Systems (EPAM) | 1.4 | $3.0M | +154% | 39k | 75.70 |
|
MercadoLibre (MELI) | 1.1 | $2.3M | -41% | 11k | 211.94 |
|
Gilead Sciences (GILD) | 0.2 | $441k | 6.5k | 68.14 |
|
|
Penumbra (PEN) | 0.2 | $355k | 4.2k | 83.92 |
|
|
Merck & Co (MRK) | 0.2 | $344k | 5.4k | 63.56 |
|
|
Vale (VALE) | 0.1 | $288k | +44% | 30k | 9.57 |
|
Pfizer (PFE) | 0.1 | $290k | 8.5k | 34.25 |
|
|
Amgen (AMGN) | 0.1 | $268k | 1.6k | 164.12 |
|
|
Eli Lilly & Co. (LLY) | 0.1 | $264k | 3.1k | 84.21 |
|
|
Ultrapar Participacoes SA (UGP) | 0.1 | $261k | -4% | 12k | 22.78 |
|
Celgene Corporation | 0.1 | $252k | 2.0k | 124.38 |
|
|
Bristol Myers Squibb (BMY) | 0.1 | $237k | 4.3k | 54.52 |
|
|
Neurocrine Biosciences (NBIX) | 0.1 | $242k | 5.6k | 43.34 |
|
|
Akorn | 0.1 | $187k | 7.8k | 24.09 |
|
|
Synergy Pharmaceuticals | 0.1 | $190k | NEW | 41k | 4.68 |
|
Arrowhead Pharmaceuticals (ARWR) | 0.1 | $193k | 103k | 1.88 |
|
|
Lannett Company | 0.1 | $142k | 6.3k | 22.46 |
|
|
Amarin Corporation (AMRN) | 0.1 | $121k | 38k | 3.19 |
|
|
Telefonica Brasil Sa | 0.1 | $106k | -8% | 7.1k | 14.84 |
|
Past Filings by Charlemagne Capital
SEC 13F filings are viewable for Charlemagne Capital going back to 2011
- Charlemagne Capital 2017 Q1 filed May 15, 2017
- Charlemagne Capital 2016 Q4 filed Feb. 13, 2017
- Charlemagne Capital 2016 Q3 filed Nov. 10, 2016
- Charlemagne Capital 2016 Q2 filed Aug. 11, 2016
- Charlemagne Capital 2016 Q1 filed May 5, 2016
- Charlemagne Capital 2015 Q4 filed Feb. 16, 2016
- Charlemagne Capital 2015 Q3 filed Nov. 9, 2015
- Charlemagne Capital 2015 Q2 filed Aug. 11, 2015
- Charlemagne Capital 2015 Q1 filed May 12, 2015
- Charlemagne Capital 2014 Q4 filed Feb. 6, 2015
- Charlemagne Capital 2014 Q3 filed Nov. 5, 2014
- Charlemagne Capital 2014 Q2 restated filed Aug. 14, 2014
- Charlemagne Capital 2014 Q2 filed Aug. 11, 2014
- Charlemagne Capital 2014 Q1 filed May 13, 2014
- Charlemagne Capital 2013 Q4 filed Feb. 11, 2014
- Charlemagne Capital 2013 Q3 filed Nov. 7, 2013